A trial has found that the burden of subclinical atrial fibrillation is not sufficient to guide the use of oral anticoagulants. This suggests that subclinical atrial fibrillation burden alone may not be a reliable factor in determining treatment. The findings of the trial indicate a potential limitation in using this factor to guide oral anticoagulant therapy.